According to Astellas Pharma's latest financial reports the company has a price-to-book ratio of 1.58198.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 1.68 | -16.68% |
2023-12-31 | 2.01 | -11.81% |
2022-12-31 | 2.28 | -3.38% |
2021-12-31 | 2.36 | 9.26% |
2020-12-31 | 2.16 | -18.38% |
2019-12-31 | 2.65 | 27.14% |
2018-12-31 | 2.08 | -1.5% |
2017-12-31 | 2.12 | -17.13% |
2016-12-31 | 2.55 | -9.5% |
2015-12-31 | 2.82 | 4.23% |
2014-12-31 | 2.71 | 14.57% |
2013-12-31 | 2.36 | 38.8% |
2012-12-31 | 1.70 | 18.02% |
2011-12-31 | 1.44 | 3.14% |
2010-12-31 | 1.40 | -14.89% |
2009-12-31 | 1.64 |